Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease mental depression
Phenotype |heart disease
Sentences 86
PubMedID- 24770757 Association of 5-htr2a and 5-htr2c serotonin receptor gene polymorphisms with depression risk in patients with coronary heart disease.
PubMedID- 26085199 Systematic review on randomized controlled trials of coronary heart disease complicated with depression treated with chinese herbal medicines.
PubMedID- 25070785 Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: role of physical activity and unmet medical need.
PubMedID- 23133583 Indeed, the single study that directly tested whether premature leukocyte shortening contributed to the excess morbidity and mortality associated with depression in patients with stable coronary heart disease found that adjusting for baseline leukocyte telomere length in depressed patients did not affect the association between depression and cardiovascular prognosis [5].
PubMedID- 23967272 A current model suggested that the somatic symptom dimension accounts for the adverse effect of depression in patients with coronary heart disease (chd).
PubMedID- 22268823 Background: prior research has shown that depression in patients with heart disease is associated with significantly impaired quality of life, decreased medication adherence, increased morbidity and increased use of healthcare services.
PubMedID- 20715885 Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.
PubMedID- 20462580 Home-based deep breathing for depression in patients with coronary heart disease: a randomised controlled trial.
PubMedID- 25255813 Background: there is a high prevalence of depression in patients with coronary heart disease that is often undetected.
PubMedID- 21663602 Moreover, increasing attempts have been made to dismantle negative affective constructs in order to identify for instance the "cardiotoxic" components of depression in patients with coronary heart disease [13].
PubMedID- 22200517 Exhaustion predicts coronary heart disease independently of symptoms of depression and anxiety in men but not in women.
PubMedID- 24166703 Adjusting for conventional risk factors logistic regression analyzed the association between cvds (peripheral vascular disease (pvd), hypertension, cerebrovascular disease and heart disease) and combinations of comorbidity between depression and anxiety disorder types (panic disorder, specific phobia, social phobia and generalized anxiety).
PubMedID- 24450968 This recognised the increased risk for depression amongst those with coronary heart disease or diabetes compared with the general population, and the association of co-morbid depression with poorer prognosis [12].
PubMedID- 23877550 In this review, epidemiology and pathophysiology of depression in patients with ischemic heart disease are described, with a focus on stratification of depressive symptoms and potential therapeutic strategies.
PubMedID- 21665006 Objective: we lack evidence that routine screening for depression in patients with coronary heart disease (chd) improves patient outcome.
PubMedID- 20813281 Background: depression in patients with stable coronary heart disease (chd) is associated with poor cardiac prognosis.
PubMedID- 26277367 depression in people with coronary heart disease: prognostic significance and mechanisms.
PubMedID- 20608826 depression in patients with heart disease: the case for more trials.
PubMedID- 23802047 depression in adults with congenital heart disease-public health challenge in a rapidly expanding new patient population.
PubMedID- 25138803 Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study.
PubMedID- 25688345 Our method of trying to achieve “fit” with the needs of end users was to use the mrc framework to guide an iterative process of consultation and intervention adaptation in our overall program of work, similar to the way barley and colleagues describe the development of their intervention for depression in patients with heart disease (26).
PubMedID- 24290037 depression screening in patients with coronary heart disease: does the evidence matter.
PubMedID- 24170724 The relationship of depression with future coronary heart disease (chd) has been a important research topic over the last 20 years and has provoked much thought on the link between the mind, brain, and heart (3,4).
PubMedID- 21772686 depression is common in patients with ischemic heart disease.
PubMedID- 21109209 Screening and identification of depression among patients with coronary heart disease and congestive heart failure.
PubMedID- 24223526 Here, the researchers analyze the burden of mdd and dysthymia in gbd 2010 by country, region, age, and sex, and calculate the burden of suicide and ischemic heart disease attributable to depressive disorders (depression is a risk factor for suicide and ischemic heart disease).
PubMedID- 24439696 The rationale for depression screening in patients with coronary heart disease.
PubMedID- 23227360 In this paper, the definition, measurement, epidemiology, mechanisms, screening, and treatment recommendations for depression comorbid with coronary heart disease will be presented, as will the controversies and future research directions in this interesting intersection between mental and physical disease.
PubMedID- 22640871 The prevalence and predictors of anxiety and depression in adolescents with heart disease.
PubMedID- 26452173 Cardiac risk markers and response to depression treatment in patients with coronary heart disease.
PubMedID- 20068189 I proposed that a cultural investigation of heart disease comorbid with depression could inform our understanding of the potential health effects of the postsocialist transition.
PubMedID- 23930029 Background: psychological risk factors such as anxiety and depression have been associated with coronary heart disease (chd).
PubMedID- 23645243 Objective: to investigate the change of serum myeloperoxidase (mpo) and lipoxin a4 (lxa4) in coronary heart disease (chd) patients with anxiety and depression and its clinical significance.
PubMedID- 20346205 Conclusion: this validation study of the iranian version of the cds demonstrated that it is an acceptable, reliable, and valid measure of depression in people with heart disease.
PubMedID- 21661300 Multimorbidity and persistent depression among veterans with diabetes, heart disease, and hypertension.
PubMedID- 23199307 Psychometric properties of the cardiac depression scale in patients with coronary heart disease.

Page: 1 2